AU2019205416B2 - Bisulfite-free, base-resolution identification of cytosine modifications - Google Patents

Bisulfite-free, base-resolution identification of cytosine modifications Download PDF

Info

Publication number
AU2019205416B2
AU2019205416B2 AU2019205416A AU2019205416A AU2019205416B2 AU 2019205416 B2 AU2019205416 B2 AU 2019205416B2 AU 2019205416 A AU2019205416 A AU 2019205416A AU 2019205416 A AU2019205416 A AU 2019205416A AU 2019205416 B2 AU2019205416 B2 AU 2019205416B2
Authority
AU
Australia
Prior art keywords
nucleic acid
dna
taps
5hmc
5cac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019205416A
Other languages
English (en)
Other versions
AU2019205416A1 (en
Inventor
Yibin Liu
Chunxiao Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Original Assignee
Ludwig Institute for Cancer Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd filed Critical Ludwig Institute for Cancer Research Ltd
Publication of AU2019205416A1 publication Critical patent/AU2019205416A1/en
Application granted granted Critical
Publication of AU2019205416B2 publication Critical patent/AU2019205416B2/en
Priority to AU2022235598A priority Critical patent/AU2022235598B2/en
Priority to AU2025201761A priority patent/AU2025201761A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01026—DNA alpha-glucosyltransferase (2.4.1.26)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01027—DNA beta-glucosyltransferase (2.4.1.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/186—Modifications characterised by incorporating a non-extendable or blocking moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164—Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2019205416A 2018-01-08 2019-01-08 Bisulfite-free, base-resolution identification of cytosine modifications Active AU2019205416B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022235598A AU2022235598B2 (en) 2018-01-08 2022-09-22 Bisulfite-free, base-resolution identification of cytosine modifications
AU2025201761A AU2025201761A1 (en) 2018-01-08 2025-03-11 Bisulfite-free, base-resolution identification of cytosine modifications

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862614798P 2018-01-08 2018-01-08
US62/614,798 2018-01-08
US201862660523P 2018-04-20 2018-04-20
US62/660,523 2018-04-20
US201862771409P 2018-11-26 2018-11-26
US62/771,409 2018-11-26
PCT/US2019/012627 WO2019136413A1 (en) 2018-01-08 2019-01-08 Bisulfite-free, base-resolution identification of cytosine modifications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022235598A Division AU2022235598B2 (en) 2018-01-08 2022-09-22 Bisulfite-free, base-resolution identification of cytosine modifications

Publications (2)

Publication Number Publication Date
AU2019205416A1 AU2019205416A1 (en) 2020-07-23
AU2019205416B2 true AU2019205416B2 (en) 2022-07-14

Family

ID=67143801

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2019205416A Active AU2019205416B2 (en) 2018-01-08 2019-01-08 Bisulfite-free, base-resolution identification of cytosine modifications
AU2022235598A Active AU2022235598B2 (en) 2018-01-08 2022-09-22 Bisulfite-free, base-resolution identification of cytosine modifications
AU2025201761A Pending AU2025201761A1 (en) 2018-01-08 2025-03-11 Bisulfite-free, base-resolution identification of cytosine modifications

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2022235598A Active AU2022235598B2 (en) 2018-01-08 2022-09-22 Bisulfite-free, base-resolution identification of cytosine modifications
AU2025201761A Pending AU2025201761A1 (en) 2018-01-08 2025-03-11 Bisulfite-free, base-resolution identification of cytosine modifications

Country Status (15)

Country Link
US (5) US12071660B2 (https=)
EP (1) EP3737748A4 (https=)
JP (3) JP7136899B2 (https=)
KR (3) KR20250026369A (https=)
CN (2) CN111971386A (https=)
AU (3) AU2019205416B2 (https=)
BR (1) BR112020013718A2 (https=)
CA (1) CA3087915C (https=)
IL (2) IL296932B2 (https=)
MA (1) MA51633A (https=)
MX (2) MX395068B (https=)
NZ (1) NZ765943A (https=)
SG (1) SG11202006511YA (https=)
WO (1) WO2019136413A1 (https=)
ZA (1) ZA202004769B (https=)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
NZ765943A (en) * 2018-01-08 2022-10-28 Ludwig Inst For Cancer Res Ltd Bisulfite-free, base-resolution identification of cytosine modifications
WO2019160994A1 (en) 2018-02-14 2019-08-22 Bluestar Genomics, Inc. Methods for the epigenetic analysis of dna, particularly cell-free dna
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
KR20220015367A (ko) 2019-05-31 2022-02-08 프리놈 홀딩스, 인크. 메틸화된 핵산의 고심도 시퀀싱 방법 및 시스템
EP3997245B1 (en) * 2019-07-08 2023-10-18 Ludwig Institute for Cancer Research Ltd Bisulfite-free, whole genome methylation analysis
AU2020345621A1 (en) * 2019-09-09 2022-04-07 University Of Utah Research Foundation Targeted sequencing to detect and quantify low levels of methylated DNA
EP4041888A4 (en) 2019-10-11 2023-11-01 Guardant Health, Inc. USE OF CELLULAR BACTERIAL NUCLEIC ACIDS FOR CANCER DETECTION
CN110669824A (zh) * 2019-10-11 2020-01-10 广州迈森致远基因科技有限公司 低起始量血浆游离dna甲基化建库试剂盒及方法
CN115087744A (zh) * 2019-11-06 2022-09-20 大学健康网络 用于无细胞MeDIP测序的合成加标对照及其使用方法
CN110820050A (zh) * 2019-11-22 2020-02-21 北京吉因加科技有限公司 全基因组甲基化非重亚硫酸氢盐测序文库及构建
WO2021161192A1 (en) 2020-02-11 2021-08-19 The Chancellor, Masters And Scholars Of The University Of Oxford Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications
CN113373207A (zh) * 2020-02-25 2021-09-10 深圳华大基因科技服务有限公司 确定胞嘧啶修饰的方法
EP4585697A3 (en) 2020-07-30 2025-08-06 Guardant Health, Inc. Methods for isolating cell-free dna
EP4083231A1 (en) 2020-07-30 2022-11-02 Cambridge Epigenetix Limited Compositions and methods for nucleic acid analysis
AU2021329899A1 (en) 2020-08-19 2023-03-09 Exact Sciences Corporation Detecting non-hodgkin lymphoma
US20230357833A1 (en) * 2020-09-14 2023-11-09 Ludwig Institute For Cancer Research Ltd Cytosine modification analysis
JP2023547620A (ja) * 2020-10-23 2023-11-13 ガーダント ヘルス， インコーポレイテッド 分配および塩基変換を使用してｄｎａを解析するための組成物および方法
GB202017653D0 (en) 2020-11-09 2020-12-23 Cambridge Entpr Ltd Methods for detection of nucleotide modification
KR20230150814A (ko) 2021-01-29 2023-10-31 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 다양한 유형의 암에 대한 존재 또는 부재의 검출
JP7646850B2 (ja) * 2021-02-09 2025-03-17 エフ． ホフマン－ラ ロシュ アーゲー 核酸中のメチル化の塩基レベル検出のための方法
KR20230156711A (ko) * 2021-03-15 2023-11-14 일루미나, 인코포레이티드 S-아데노실-L-메티오닌 유사체(xSAM)를 사용한 메틸시토신 및 이의 유도체의 검출
GB202109469D0 (en) 2021-06-30 2021-08-11 Cambridge Entpr Ltd Methods for detecting modified nucleotides
CA3226747A1 (en) * 2021-07-27 2023-02-02 Chunxiao Song Compositions and methods related to tet-assisted pyridine borane sequencing for cell-free dna
CN113846160B (zh) * 2021-09-14 2024-08-20 翌圣生物科技(上海)股份有限公司 正向筛选的胞嘧啶甲基化快速检测方法及过氧钨酸盐在将5hmC氧化为thT中的应用
CN114085894A (zh) * 2021-11-03 2022-02-25 翌圣生物科技(上海)股份有限公司 核酸甲基化胞嘧啶转化方法
CN118202065A (zh) * 2021-11-15 2024-06-14 深圳华大智造科技股份有限公司 一种检测全基因组范围内的dna甲基化修饰的方法
EP4457357A4 (en) * 2021-12-29 2026-01-07 Found Medicine Inc DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW
CN114045345B (zh) * 2022-01-07 2022-04-29 臻和(北京)生物科技有限公司 基于游离dna的基因组癌变信息检测系统和检测方法
AU2023234670A1 (en) * 2022-03-15 2024-01-18 Illumina, Inc. Concurrent sequencing of forward and reverse complement strands on separate polynucleotides for methylation detection
WO2023183841A2 (en) * 2022-03-23 2023-09-28 Exact Sciences Corporation Compositions and methods for tet-assisted oxidation of methylated nucleotide bases
EP4499859A1 (en) 2022-03-31 2025-02-05 Illumina, Inc. Compositions including aqueous amine borane complexes and polynucleotides, and methods of using the same to detect methylcytosine or hydroxymethylcytosine
WO2024042217A1 (en) 2022-08-25 2024-02-29 Illumina, Inc. Methods of modifying methylcytosine or derivative thereof using a nucleophilic molecule, and methods of using the same to detect the methylcytosine or derivative thereof in a polynucleotide
WO2024073043A1 (en) 2022-09-30 2024-04-04 Illumina, Inc. Methods of using cpg binding proteins in mapping modified cytosine nucleotides
EP4658807A1 (en) 2023-02-01 2025-12-10 Illumina, Inc. Methods of modifying methylcytosine or derivative thereof using a photoredox reaction, and methods of using the same to detect the methylcytosine or derivative thereof in a polynucleotide
WO2024164173A1 (en) * 2023-02-08 2024-08-15 Peking University 5-hydroxymethylcytosine sequencing
CN116287166A (zh) * 2023-04-19 2023-06-23 纳昂达(南京)生物科技有限公司 甲基化测序接头及其应用
KR20260005347A (ko) 2023-04-28 2026-01-09 이그잭트 사이언시스 이노베이션 리미티드 조작된 tet 효소 및 후성유전학 및 차세대 서열분석(ngs), 예컨대 tet-보조 피리딘 보란 서열분석(taps)에서의 용도
WO2024249061A1 (en) * 2023-05-31 2024-12-05 Illumina, Inc. Detecting a methylated nucleotide using a quencher
WO2025054389A1 (en) * 2023-09-07 2025-03-13 Illumina, Inc. Identification of methylated cytosine using landmarks
WO2025085492A1 (en) * 2023-10-17 2025-04-24 Exact Sciences Corporation Borane reducing reagents
WO2026055641A1 (en) 2024-09-06 2026-03-12 Exact Sciences Corporation Methods and compositions for preparing biomolecule analytes from complex samples
WO2026072259A1 (en) 2024-09-30 2026-04-02 Illumina, Inc. Methods, systems, and kits for sequencing nucleic acids with deamination and mutagenesis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140322707A1 (en) * 2011-04-06 2014-10-30 The University Of Chicago COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5-mC)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US9115386B2 (en) 2008-09-26 2015-08-25 Children's Medical Center Corporation Selective oxidation of 5-methylcytosine by TET-family proteins
WO2011127136A1 (en) 2010-04-06 2011-10-13 University Of Chicago Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc)
RU2612902C2 (ru) 2011-07-29 2017-03-13 Кембридж Эпидженетикс Лимитед Способы обнаружения модификации нуклеотидов
JP6224689B2 (ja) 2012-03-15 2017-11-01 ニユー・イングランド・バイオレイブス・インコーポレイテツド シトシンとこれの修飾物とを識別するための、およびメチローム分析のための方法および組成物
US9267117B2 (en) * 2012-03-15 2016-02-23 New England Biolabs, Inc. Mapping cytosine modifications
WO2014165770A1 (en) * 2013-04-05 2014-10-09 The University Of Chicago Single-base resolution sequencing of 5-formylcytosine (5fc) and 5-carboxylcytosine (5cac)
US20160194696A1 (en) 2013-08-09 2016-07-07 New England Biolabs, Inc. Detecting, Sequencing and/or Mapping 5-Hydroxymethylcytosine and 5-Formylcytosine at Single-Base Resolution
WO2017039002A1 (ja) 2015-09-04 2017-03-09 国立大学法人東京大学 ５－ヒドロキシメチルシトシン酸化剤及び５－ヒドロキシメチルシトシン解析方法
US11162139B2 (en) 2016-03-02 2021-11-02 Shanghai Epican Genetech Co. Ltd. Method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine
WO2017176630A1 (en) 2016-04-07 2017-10-12 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna
NZ765943A (en) 2018-01-08 2022-10-28 Ludwig Inst For Cancer Res Ltd Bisulfite-free, base-resolution identification of cytosine modifications
WO2019160994A1 (en) 2018-02-14 2019-08-22 Bluestar Genomics, Inc. Methods for the epigenetic analysis of dna, particularly cell-free dna

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140322707A1 (en) * 2011-04-06 2014-10-30 The University Of Chicago COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5-mC)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ITO, S. et al., "Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine", Science, 2011, Vol. 333, pp 1300-1303 *
LIU ET AL.: "Bisulfite-Free, Base-Resolution, and Quantitative Sequencing of Cytosine Modifications", BIORXIV, 25 April 2018 (2018-04-25), pages 1 - 18 *
LIU YIBIN ET AL: "Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution", NATURE BIOTECHNOLOGY, 2019, vol. 37, no. 4, pages 424 - 429 *

Also Published As

Publication number Publication date
WO2019136413A1 (en) 2019-07-11
SG11202006511YA (en) 2020-08-28
US20210317519A1 (en) 2021-10-14
KR102503884B1 (ko) 2023-03-07
JP7136899B2 (ja) 2022-09-13
US11987843B2 (en) 2024-05-21
US20250011861A1 (en) 2025-01-09
KR20200108319A (ko) 2020-09-17
CN115181783A (zh) 2022-10-14
US20200370114A1 (en) 2020-11-26
NZ765943A (en) 2022-10-28
ZA202004769B (en) 2023-07-26
EP3737748A4 (en) 2021-10-20
MA51633A (fr) 2020-11-18
MX395068B (es) 2025-03-24
KR20230030037A (ko) 2023-03-03
JP2022174153A (ja) 2022-11-22
JP2021509587A (ja) 2021-04-01
JP2024161477A (ja) 2024-11-19
IL275850B2 (en) 2023-03-01
AU2022235598A1 (en) 2022-11-03
MX2020007259A (es) 2022-08-26
CA3087915C (en) 2025-06-10
MX2022010611A (es) 2022-09-21
US11959136B2 (en) 2024-04-16
EP3737748A1 (en) 2020-11-18
IL296932A (en) 2022-12-01
BR112020013718A2 (pt) 2020-12-01
IL275850A (en) 2020-08-31
US12071660B2 (en) 2024-08-27
US11306355B2 (en) 2022-04-19
KR102768046B1 (ko) 2025-02-17
AU2019205416A1 (en) 2020-07-23
AU2022235598B2 (en) 2025-01-23
IL296932B1 (en) 2025-09-01
US20220282323A1 (en) 2022-09-08
CN111971386A (zh) 2020-11-20
CA3087915A1 (en) 2019-07-11
WO2019136413A4 (en) 2019-08-29
JP7539948B2 (ja) 2024-08-26
US20220213543A1 (en) 2022-07-07
AU2025201761A1 (en) 2025-04-03
KR20250026369A (ko) 2025-02-25
IL275850B (en) 2022-11-01
IL296932B2 (en) 2026-01-01

Similar Documents

Publication Publication Date Title
US11959136B2 (en) Bisulfite-free, base-resolution identification of cytosine modifications
AU2020310613B2 (en) Bisulfite-free, whole genome methylation analysis
CA3146212C (en) Bisulfite-free, whole genome methylation analysis
HK40103747A (en) Bisulfite-free, whole genome methylation analysis
HK40069820B (en) Bisulfite-free, whole genome methylation analysis
HK40069820A (en) Bisulfite-free, whole genome methylation analysis
NZ793130A (en) Bisulfite-free, base-resolution identification of cytosine modifications
EA047457B1 (ru) Модификация цитозина без применения бисульфита с разрешением до одного основания

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)